Univest
Univest
  • Markets
  • Sensex Prediction for Tomorrow, 11 August 2026: Index at 78,542 as ICICI Bank Bounce and Bajaj Finance Recovery Offset SBI’s Post-Q1 Profit Booking

    • August 10, 2026
    • Posted by: Lakshit Sharma
    • Category: News
    No Comments
    Sensex Prediction for Tomorrow, 11 August 2026: Index at 78,542 as ICICI Bank Bounce and Bajaj Finance Recovery Offset SBI's Post-Q1 Profit Booking

    Sensex prediction for tomorrow 11 Aug: 78,542.44 (+0.06%). ICICI +0.76% added 55 pts. SBI -2.39% dragged. Bajaj Fin +2.24% recovered. Support 78,280-78,380.

    read more
  • Bank Nifty Prediction for Tomorrow, 11 August 2026: Day 4 Rotation Sets Up as SBI Post-Q1 Booking Meets ICICI Bank Recovery at Monday’s Close of 57,686

    • August 10, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Bank Nifty Prediction for Tomorrow, 11 August 2026: Day 4 Rotation Sets Up as SBI Post-Q1 Booking Meets ICICI Bank Recovery at Monday's Close of 57,686

    Bank Nifty prediction for tomorrow 11 Aug: 57,686.95 (-0.10%). SBI -2.39% post-Q1 drag. ICICI +0.76%. HDFC flat Rs 731. High 58,012 today. Support 57,500-57,600

    read more
  • Rategain Travel Technologies Share: Pros and Cons Every Investor Must Know in 2026

    • August 10, 2026
    • Posted by: Lakshit Sharma
    • Category: News
    No Comments
    Rategain Travel Technologies Share: Pros and Cons Every Investor Must Know in 2026

    Rategain Travel Technologies share pros and cons: world’s largest travel SaaS company at 72.45x PE with global hotel and airline customers analysed for 2026.

    read more
  • Campus Activewear Share: Pros and Cons Every Investor Must Know in 2026

    • August 10, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    Campus Activewear Share: Pros and Cons Every Investor Must Know in 2026

    Campus Activewear share pros and cons: India’s largest domestic sports footwear brand at approximately 40x PE with mass market positioning and Nike and Adidas competition analysed for 2026.

    read more
  • Spandana Sphoorty Financial Share: Pros and Cons Every Investor Must Know in 2026

    • August 10, 2026
    • Posted by: Kunal Singla
    • Category: News
    No Comments
    Spandana Sphoorty Financial Share: Pros and Cons Every Investor Must Know in 2026

    Spandana Sphoorty share pros and cons: loss-making MFI NBFC at distressed MCap with binary turnaround outcome risk — not for risk-averse investors analysed for 2026.

    read more
  • Indegene Share: Pros and Cons Every Investor Must Know in 2026

    • August 10, 2026
    • Posted by: Lakshit Sharma
    • Category: News
    No Comments
    Indegene Share: Pros and Cons Every Investor Must Know in 2026

    Indegene share pros and cons: India’s only listed pharma digital health technology company at 40.47x PE with Big Pharma client stickiness analysed for 2026.

    read more
  • TCI Express Share: Pros and Cons Every Investor Must Know in 2026

    • August 10, 2026
    • Posted by: Lakshit Sharma
    • Category: News
    No Comments
    TCI Express Share: Pros and Cons Every Investor Must Know in 2026

    TCI Express share pros and cons: India’s leading B2B surface express logistics at approximately 32x PE with exceptional 22.97% ROE and manufacturing supply chain demand growth analysed for 2026.

    read more
  • Go Fashion India Share: Pros and Cons Every Investor Must Know in 2026

    • August 10, 2026
    • Posted by: Lakshit Sharma
    • Category: News
    No Comments
    Go Fashion India Share: Pros and Cons Every Investor Must Know in 2026

    Go Fashion share pros and cons: India’s leading women bottom-wear specialty retailer at approximately 65x PE with category creator moat and quality 20.18% ROE analysed for 2026.

    read more
  • Gland Pharma Share: Pros and Cons Every Investor Must Know in 2026

    • August 10, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    Gland Pharma Share: Pros and Cons Every Investor Must Know in 2026

    Gland Pharma share pros and cons: India’s largest injectable pharma at 58.39x PE with Chinese parent Fosun ownership risk and US generic price erosion analysed for 2026.

    read more
  • Sun TV Network Share: Pros and Cons Every Investor Must Know in 2026

    • August 10, 2026
    • Posted by: Lakshit Sharma
    • Category: News
    No Comments
    Sun TV Network Share: Pros and Cons Every Investor Must Know in 2026

    Sun TV Network share pros and cons: South India’s dominant regional TV network at approximately 16x PE with extraordinary 40% ROE and OTT disruption risk analysed for 2026.

    read more
  • 1
  • …
  • 800
  • 801
  • 802
  • 803
  • 804
  • …
  • 2,715